Cyclic AMP accumulation in rabbit aorta smooth muscle cells altered in the presence of hyperlipidemic serum.

[1]  Y. Kishi,et al.  Contractions in normal and atherosclerotic rabbit aortas , 1984, Mechanisms of Ageing and Development.

[2]  M. Caron,et al.  Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. , 1984, The New England journal of medicine.

[3]  A. Mark,et al.  Augmented Responses to Vasoconstrictor Stimuli in Hypercholesterolemic and Atherosclerotic Monkeys , 1984, Circulation research.

[4]  R. Haslam,et al.  Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). , 1982, The Journal of biological chemistry.

[5]  Y. Kishi,et al.  A study of the mechanism of estrogen as an antiatherosclerotic: The inhibitory effect of estrogen on A23187-induced contraction of the aortic wall , 1982, Mechanisms of Ageing and Development.

[6]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[7]  M. Shinitzky,et al.  Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Butcher,et al.  Turnover of adenosine 3',5'-monophosphate in WI-38 cultured fibroblasts. , 1980, Biochemistry.

[9]  F. Numano.  Chemotherapy of Atherosclerosis : Symposium on Atherosclerosis; Its Progression and Regression , 1980 .

[10]  P. D. Henry,et al.  Sensitization of Isolated Canine Coronary Arteries to Calcium Ions after Exposure to Cholesterol , 1979, Circulation research.

[11]  S. Snyder,et al.  (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. , 1978, The Journal of biological chemistry.

[12]  J. Heider,et al.  The picomole determination of free and total cholesterol in cells in culture. , 1978, Journal of Lipid Research.

[13]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[14]  K. Fischer-Dzoga,et al.  Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph. , 1976, Experimental and molecular pathology.

[15]  G. S. Johnson,et al.  Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts. , 1972, The Journal of biological chemistry.

[16]  R. Ross.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. , 1971 .

[17]  Thompson Wj,et al.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain , 1971 .

[18]  S. Arfin.  Evidence for an Enol Intermediate in the Enzymatic Conversion of α,β-Dihydroxyisovalerate to α-Ketoisovalerate , 1969 .

[19]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[20]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[21]  R. Stout,et al.  Dibutyryl cyclic AMP inhibits LDL binding in cultured fibroblasts and arterial smooth muscle cells. , 1983, Atherosclerosis.

[22]  M. Shinitzky,et al.  The modulation of protein phosphorylation and receptor binding in synaptic membranes by changes in lipid fluidity: implications for ageing. , 1982, Progress in brain research.

[23]  Y. Salomon.  Adenylate cyclase assay. , 1979, Advances in cyclic nucleotide research.